Heidi Hongisto

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2022
Publications (10 Years): 4

Top Topics

Pluripotent Stem Cells

Extracellular Matrix

Diabetic Retinopathy

Top Venues

The Journal of pathology

International journal of molecular sciences

Stem cell research & therapy

University of Eastern Finland

University of Tampere (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Eastern Finland Sep 1o 2018

Finland

Academy of Finland postdoctoral researcher :: Department of Ophthalmology

Education History

University of Tampere Oct 1o 2006 - Feb 26o 2013

Finland

PHD :: Institute of Biomedical Technology

Publications

Laura Hellinen, Heidi Hongisto, Eva Ramsay, Kai Kaarniranta, Kati-Sisko Vellonen, Heli Skottman, Marika Ruponen
Retraction: Hellinen et al. Drug Flux across RPE Cell Models: The Hunt for an Appropriate Outer Blood-Retinal Barrier Model for Use in Early Drug Discovery. Pharmaceutics 2020, 12 , 176. Pharmaceutics 14 (3) (2022)
Maria Hytti, Eveliina Korhonen, Heidi Hongisto, Kai Kaarniranta, Heli Skottman, Anu Kauppinen
Differential Expression of Inflammasome-Related Genes in Induced Pluripotent Stem-Cell-Derived Retinal Pigment Epithelial Cells with or without History of Age-Related Macular Degeneration. International journal of molecular sciences 22 (13) (2021)
Heidi Hongisto, Jennifer M Dewing, David Rg Christensen, Jennifer Scott, Angela J Cree, Janika Nättinen, Juha Määttä, Antti Jylhä, Ulla Aapola, Hannu Uusitalo, Kai Kaarniranta, J Arjuna Ratnayaka, Heli Skottman, Andrew John Lotery
In vitro stem cell modelling demonstrates a proof-of-concept for excess functional mutant TIMP3 as the cause of Sorsby fundus dystrophy. The Journal of pathology 252 (2) (2020)
Heidi Hongisto, Tanja Ilmarinen, Meri Vattulainen, Alexandra Mikhailova, Heli Skottman
Xeno- and feeder-free differentiation of human pluripotent stem cells to two distinct ocular epithelial cell types using simple modifications of one method. Stem cell research & therapy 8 (1) (2017)